Molson Coors Canada Inc.
Molson Coors Canada Inc. (MXGBF) Financial Performance & Income Statement Overview
Analyze Molson Coors Canada Inc. (MXGBF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Molson Coors Canada Inc. (MXGBF) Income Statement & Financial Overview
Review Molson Coors Canada Inc. MXGBF income statement with detailed quarterly and annual figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $2.30B | $2.74B | $3.04B | $3.25B |
| Cost of Revenue | $1.45B | $1.70B | $1.84B | $1.92B |
| Gross Profit | $850.90M | $1.04B | $1.20B | $1.33B |
| Gross Profit Ratio | $0.37 | $0.38 | $0.40 | $0.41 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $653.20M | $649.70M | $684.70M | $728.50M |
| Operating Expenses | $664.60M | $649.40M | $751.30M | $730.30M |
| Total Costs & Expenses | $2.12B | $2.35B | $2.59B | $2.64B |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $180.30M | $247.30M | $175.40M | $167.70M |
| EBITDA | $378.00M | $604.90M | $693.20M | $776.40M |
| EBITDA Ratio | $0.16 | $0.22 | $0.23 | $0.24 |
| Operating Income | $186.30M | $388.10M | $451.20M | $608.80M |
| Operating Income Ratio | $0.08 | $0.14 | $0.15 | $0.19 |
| Other Income/Expenses (Net) | -$30.00M | -$41.80M | -$119.80M | -$39.70M |
| Income Before Tax | $156.30M | $346.30M | $331.40M | $559.90M |
| Income Before Tax Ratio | $0.07 | $0.13 | $0.11 | $0.17 |
| Income Tax Expense | $33.20M | $52.60M | $102.60M | $134.60M |
| Net Income | $121.00M | $287.80M | $199.80M | $427.00M |
| Net Income Ratio | $0.05 | $0.11 | $0.07 | $0.13 |
| EPS | $0.60 | $1.37 | $0.95 | $2.03 |
| Diluted EPS | $0.59 | $1.37 | $0.95 | $2.03 |
| Weighted Avg Shares Outstanding | $203.00M | $210.34M | $210.34M | $210.34M |
| Weighted Avg Shares Outstanding (Diluted) | $204.00M | $210.80M | $210.80M | $210.80M |
Financial performance has remained strong, with revenue growing from $3.25B in Q2 2024 to $2.30B in Q1 2025. Gross profit continued to perform well, with margins at 37% in the latest quarter. Operating income reached $186.30M in Q1 2025, holding a steady 8% margin. While R&D and SG&A expenses fluctuated, EBITDA remained robust at $378.00M. Net income dropped to $121.00M, keeping EPS at $0.60. With disciplined cost control and operational efficiency, the company supported consistent profitability, reflecting its ability to deliver stable shareholder value.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan